Organization | Stockholm South General Hospital

Stockholm South General Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial

2001

NCT00806403

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Stockholm South General Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

reteplase (Retavase) (1 trial)

Drugs in Phase 3 Trials (4)

hydrocortisone (solu-cortef) (1 trial)

methylprednisolone (medrol) (1 trial)

sodium chloride (1 trial)

vasopressin (vasostrict) (1 trial)

Drugs in Other Trials (5)

cyclophosphamide (cytoxan) (1 trial)

docetaxel (taxotere) (1 trial)

epirubicin (ellence) (1 trial)

fluorouracil (efudex) (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 10